Published in Oncogene on January 14, 2008
Molecular genetics of prostate cancer: new prospects for old challenges. Genes Dev (2010) 5.83
Dissecting the unique role of the retinoblastoma tumor suppressor during cellular senescence. Cancer Cell (2010) 3.81
Cellular senescence and the senescent secretory phenotype: therapeutic opportunities. J Clin Invest (2013) 3.47
p38MAPK is a novel DNA damage response-independent regulator of the senescence-associated secretory phenotype. EMBO J (2011) 2.61
The Emerging Hallmarks of Cancer Metabolism. Cell Metab (2016) 2.32
TGF-beta signaling engages an ATM-CHK2-p53-independent RAS-induced senescence and prevents malignant transformation in human mammary epithelial cells. Proc Natl Acad Sci U S A (2011) 1.94
Suppression of nucleotide metabolism underlies the establishment and maintenance of oncogene-induced senescence. Cell Rep (2013) 1.74
Oncogene-induced telomere dysfunction enforces cellular senescence in human cancer precursor lesions. EMBO J (2012) 1.71
The miR-17-92 cluster of microRNAs confers tumorigenicity by inhibiting oncogene-induced senescence. Cancer Res (2010) 1.60
Human lung epithelial cells progressed to malignancy through specific oncogenic manipulations. Mol Cancer Res (2013) 1.57
BRD4 Connects Enhancer Remodeling to Senescence Immune Surveillance. Cancer Discov (2016) 1.54
Elucidating distinct roles for NF1 in melanomagenesis. Cancer Discov (2012) 1.53
Monoallelic loss of the imprinted gene Grb10 promotes tumor formation in irradiated Nf1+/- mice. PLoS Genet (2015) 1.40
RB1, development, and cancer. Curr Top Dev Biol (2011) 1.37
The atypical E2F family member E2F7 couples the p53 and RB pathways during cellular senescence. Genes Dev (2012) 1.33
Growth signaling promotes chronological aging in budding yeast by inducing superoxide anions that inhibit quiescence. Aging (Albany NY) (2010) 1.33
Cellular features of senescence during the evolution of human and murine ductal pancreatic cancer. Oncogene (2011) 1.32
A kinase shRNA screen links LATS2 and the pRB tumor suppressor. Genes Dev (2011) 1.30
Molecular damage in cancer: an argument for mTOR-driven aging. Aging (Albany NY) (2011) 1.29
H3K4 demethylation by Jarid1a and Jarid1b contributes to retinoblastoma-mediated gene silencing during cellular senescence. Proc Natl Acad Sci U S A (2012) 1.28
Targeting of the MNK-eIF4E axis in blast crisis chronic myeloid leukemia inhibits leukemia stem cell function. Proc Natl Acad Sci U S A (2013) 1.19
Complete deletion of Apc results in severe polyposis in mice. Oncogene (2009) 1.16
Jnk2 effects on tumor development, genetic instability and replicative stress in an oncogene-driven mouse mammary tumor model. PLoS One (2010) 1.12
Emerging roles of the p38 MAPK and PI3K/AKT/mTOR pathways in oncogene-induced senescence. Trends Biochem Sci (2014) 1.10
Splicing-factor oncoprotein SRSF1 stabilizes p53 via RPL5 and induces cellular senescence. Mol Cell (2013) 1.10
The specific role of pRb in p16 (INK4A) -mediated arrest of normal and malignant human breast cells. Cell Cycle (2012) 1.10
SnoN functions as a tumour suppressor by inducing premature senescence. EMBO J (2009) 1.09
Inflammatory signaling and cellular senescence. Cell Signal (2008) 1.08
The DNA damage response: Balancing the scale between cancer and ageing. Aging (Albany NY) (2010) 1.08
MDM2 turnover and expression of ATRX determine the choice between quiescence and senescence in response to CDK4 inhibition. Oncotarget (2015) 1.05
Controversial aspects of oncogene-induced senescence. Cell Cycle (2012) 1.04
RUNX1 and its fusion oncoprotein derivative, RUNX1-ETO, induce senescence-like growth arrest independently of replicative stress. Oncogene (2009) 1.03
A mortalin/HSPA9-mediated switch in tumor-suppressive signaling of Raf/MEK/extracellular signal-regulated kinase. Mol Cell Biol (2013) 1.02
Copy number gain and oncogenic activity of YWHAZ/14-3-3zeta in head and neck squamous cell carcinoma. Int J Cancer (2009) 1.01
The FHIT gene product: tumor suppressor and genome "caretaker". Cell Mol Life Sci (2014) 1.01
Cooperative functions of Chk1 and Chk2 reduce tumour susceptibility in vivo. EMBO J (2010) 1.00
Proteinopathy-induced neuronal senescence: a hypothesis for brain failure in Alzheimer's and other neurodegenerative diseases. Alzheimers Res Ther (2009) 1.00
The replicometer is broken: telomeres activate cellular senescence in response to genotoxic stresses. Aging Cell (2014) 1.00
Genetic and epigenetic mutations of tumor suppressive genes in sporadic pituitary adenoma. Mol Cell Endocrinol (2013) 0.99
Cellular senescence and cancer chemotherapy resistance. Drug Resist Updat (2012) 0.99
A posttranslational modification cascade involving p38, Tip60, and PRAK mediates oncogene-induced senescence. Mol Cell (2013) 0.98
The histone demethylase Jarid1b (Kdm5b) is a novel component of the Rb pathway and associates with E2f-target genes in MEFs during senescence. PLoS One (2011) 0.98
Lamin A, farnesylation and aging. Exp Cell Res (2011) 0.97
Wnt signaling in cancer. Oncogene (2016) 0.95
Oncogenic stress induced by acute hyper-activation of Bcr-Abl leads to cell death upon induction of excessive aerobic glycolysis. PLoS One (2011) 0.94
Irreparable telomeric DNA damage and persistent DDR signalling as a shared causative mechanism of cellular senescence and ageing. Curr Opin Genet Dev (2014) 0.93
Insulin-like growth factor-1 regulates the SIRT1-p53 pathway in cellular senescence. Aging Cell (2014) 0.92
Oncogene-induced senescence: an essential role for Runx. Cell Cycle (2008) 0.92
Mad2 and BubR1 modulates tumourigenesis and paclitaxel response in MKN45 gastric cancer cells. Cell Cycle (2014) 0.92
Protein degradation and the stress response. Semin Cell Dev Biol (2012) 0.91
Silencing nuclear pore protein Tpr elicits a senescent-like phenotype in cancer cells. PLoS One (2011) 0.91
Cellular senescence induced by aberrant MAD2 levels impacts on paclitaxel responsiveness in vitro. Br J Cancer (2009) 0.91
Minireview: physiological and pathological actions of RAS in the ovary. Mol Endocrinol (2009) 0.91
Growth arrest signaling of the Raf/MEK/ERK pathway in cancer. Front Biol (Beijing) (2014) 0.90
The atypical CDK activator Spy1 regulates the intrinsic DNA damage response and is dependent upon p53 to inhibit apoptosis. Cell Cycle (2009) 0.90
Activation of the aryl hydrocarbon receptor by TCDD inhibits senescence: a tumor promoting event? Biochem Pharmacol (2008) 0.90
The Conundrum of Genetic "Drivers" in Benign Conditions. J Natl Cancer Inst (2016) 0.90
Quantitation and Identification of Thousands of Human Proteoforms below 30 kDa. J Proteome Res (2016) 0.90
Thrombospondin-1 mediates oncogenic Ras-induced senescence in premalignant lung tumors. J Clin Invest (2013) 0.90
58-kDa microspherule protein (MSP58) is novel Brahma-related gene 1 (BRG1)-associated protein that modulates p53/p21 senescence pathway. J Biol Chem (2012) 0.89
Linking JNK Activity to the DNA Damage Response. Genes Cancer (2013) 0.89
Chronic NF-kappaB activation delays RasV12-induced premature senescence of human fibroblasts by suppressing the DNA damage checkpoint response. Mech Ageing Dev (2009) 0.88
The retinoblastoma protein selectively represses E2F1 targets via a TAAC DNA element during cellular senescence. J Biol Chem (2012) 0.87
Murine models and cell lines for the investigation of pheochromocytoma: applications for future therapies? Endocr Pathol (2012) 0.87
E2f binding-deficient Rb1 protein suppresses prostate tumor progression in vivo. Proc Natl Acad Sci U S A (2010) 0.86
From Ancient Pathways to Aging Cells-Connecting Metabolism and Cellular Senescence. Cell Metab (2016) 0.86
The ING tumor suppressors in cellular senescence and chromatin. Cell Biosci (2011) 0.85
The nuclear receptor peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) promotes oncogene-induced cellular senescence through repression of endoplasmic reticulum stress. J Biol Chem (2014) 0.85
Cellular senescence as a target in cancer control. J Aging Res (2010) 0.85
p53-dependent induction of prostate cancer cell senescence by the PIM1 protein kinase. Mol Cancer Res (2010) 0.85
HiJAK'd Signaling; the STAT3 Paradox in Senescence and Cancer Progression. Cancers (Basel) (2014) 0.85
Cell biology. The TASCC of secretion. Science (2011) 0.85
Identification of ribonucleotide reductase M2 as a potential target for pro-senescence therapy in epithelial ovarian cancer. Cell Cycle (2013) 0.84
PKD1 mediates negative feedback of PI3K/Akt activation in response to G protein-coupled receptors. PLoS One (2013) 0.84
STAT3-mediated SMAD3 activation underlies Oncostatin M-induced Senescence. Cell Cycle (2016) 0.83
Therapeutic targeting of replicative immortality. Semin Cancer Biol (2015) 0.83
PPARβ/δ promotes HRAS-induced senescence and tumor suppression by potentiating p-ERK and repressing p-AKT signaling. Oncogene (2013) 0.83
The impact of cellular senescence in cancer therapy: is it true or not? Acta Pharmacol Sin (2011) 0.81
The role of senescence and prosurvival signaling in controlling the oncogenic activity of FGFR2 mutants associated with cancer and birth defects. Hum Mol Genet (2009) 0.81
Connecting the Dots: From DNA Damage and Repair to Aging. Int J Mol Sci (2016) 0.80
Interleukin-4 induces senescence in human renal carcinoma cell lines through STAT6 and p38 MAPK. J Biol Chem (2013) 0.80
The Role of STAT3 in Thyroid Cancer. Cancers (Basel) (2014) 0.80
Redox control of senescence and age-related disease. Redox Biol (2016) 0.79
SIRT1 is required for oncogenic transformation of neural stem cells and for the survival of "cancer cells with neural stemness" in a p53-dependent manner. Neuro Oncol (2014) 0.79
PAG/Cbp suppression reveals a contribution of CTLA-4 to setting the activation threshold in T cells. Cell Commun Signal (2013) 0.79
Widespread genomic instability mediated by a pathway involving glycoprotein Ib alpha and Aurora B kinase. J Biol Chem (2010) 0.79
Changed genome heterochromatinization upon prolonged activation of the Raf/ERK signaling pathway. PLoS One (2010) 0.79
Mitochondrial dynamics as regulators of cancer biology. Cell Mol Life Sci (2017) 0.79
Multiple facets of p53 in senescence induction and maintenance. Cancer Sci (2016) 0.79
Disruptive chemicals, senescence and immortality. Carcinogenesis (2015) 0.78
ERK and JNK activation is essential for oncogenic transformation by v-Rel. Oncogene (2010) 0.77
Senescence-associated Long Non-coding RNA (SALNR) Delays Oncogene-induced Senescence through NF90 Regulation. J Biol Chem (2015) 0.77
Inducing cellular senescence in vitro by using genetically encoded photosensitizers. Aging (Albany NY) (2016) 0.76
A critical role for TORC1 in cellular senescence. Cell Cycle (2012) 0.76
Cellular senescence in livers from children with end stage liver disease. PLoS One (2010) 0.76
TSH overcomes Braf(V600E)-induced senescence to promote tumor progression via downregulation of p53 expression in papillary thyroid cancer. Oncogene (2015) 0.75
The Chromatin Landscape of Cellular Senescence. Trends Genet (2016) 0.75
MSK1 triggers the expression of the INK4AB/ARF locus in oncogene-induced senescence. Mol Biol Cell (2016) 0.75
Epigenetic alteration to activate Bmp2-Smad signaling in Raf-induced senescence. World J Biol Chem (2016) 0.75
SENP1 Is a Crucial Regulator for Cell Senescence through DeSUMOylation of Bmi1. Sci Rep (2016) 0.75
K-ras is an essential gene in the mouse with partial functional overlap with N-ras. Genes Dev (1997) 4.24
Skin biopsy in general practice. BMJ (1991) 3.49
Sensitivity and specificity of a gamma interferon blood test for tuberculosis infection. Int J Tuberc Lung Dis (1998) 2.50
A sandwich enzyme immunoassay for bovine interferon-gamma and its use for the detection of tuberculosis in cattle. Aust Vet J (1990) 2.04
Field comparison of the interferon-gamma assay and the intradermal tuberculin test for the diagnosis of bovine tuberculosis. Aust Vet J (1991) 1.82
Structure-function relationships in the activation of platelet thrombin receptors by receptor-derived peptides. J Biol Chem (1992) 1.74
Melanopsin-dependent photoreception provides earliest light detection in the mammalian retina. Curr Biol (2005) 1.69
Development of a human gamma interferon enzyme immunoassay and comparison with tuberculin skin testing for detection of Mycobacterium tuberculosis infection. Clin Diagn Lab Immunol (1998) 1.64
Multivariate analysis of improvement and outcome following stroke rehabilitation. Arch Neurol (1987) 1.57
Glomerular hyperfiltration as a risk factor for diabetic nephropathy: five-year report of a prospective study. Diabetologia (1991) 1.55
Comparison of a tuberculin interferon-gamma assay with the tuberculin skin test in high-risk adults: effect of human immunodeficiency virus infection. J Infect Dis (1997) 1.54
More on confidentiality. Arch Psychiatr Nurs (1993) 1.48
Sensitivity and specificity of two serological tests for the detection of ovine paratuberculosis. Aust Vet J (2000) 1.46
Transvaginal chorionic villus sampling. Prenat Diagn (1990) 1.41
Do we have a choice? Arch Psychiatr Nurs (1998) 1.39
BOVIGAM: an in vitro cellular diagnostic test for bovine tuberculosis. Tuberculosis (Edinb) (2001) 1.36
Structure and function of the human platelet thrombin receptor. Studies using monoclonal antibodies directed against a defined domain within the receptor N terminus. J Biol Chem (1992) 1.25
Signaling through G proteins in platelets: to the integrins and beyond. Thromb Haemost (1997) 1.22
Electrolyte disturbances in foals with severe rhabdomyolysis. J Vet Intern Med (1998) 1.20
The gamma-interferon assay for diagnosis of bovine tuberculosis in cattle: conditions affecting the production of gamma-interferon in whole blood culture. Aust Vet J (1992) 1.16
A human breast tissue-associated antigen detected by a monoclonal antibody. J Natl Cancer Inst (1983) 1.16
Immunoglobulin kappa gene expression after stable integration. II. Role of the intronic MAR and enhancer in transgenic mice. J Biol Chem (1989) 1.16
Development and evaluation of a rapid absorbed enzyme immunoassay test for the diagnosis of Johne's disease in cattle. Aust Vet J (1991) 1.02
A functional granulocyte colony-stimulating factor receptor is required for normal chemoattractant-induced neutrophil activation. J Clin Invest (1999) 0.98
Tuberculosis in Tanzanian wildlife. J Wildl Dis (2005) 0.97
Characterization of coeruleospinal inhibition of the nociceptive tail-flick reflex in the rat: mediation by spinal alpha 2-adrenoceptors. Brain Res (1986) 0.97
Osteoporosis education programs: changing knowledge and behaviors. Public Health Nurs (2000) 0.95
Quantitative characterization of ceruleospinal inhibition of nociceptive transmission in the rat. J Neurophysiol (1986) 0.95
Glomerular hyperfiltration in the prediction of nephropathy in IDDM: a 10-year follow-up study. Diabetes (1996) 0.95
Comparison of purified protein derivatives and effect of skin testing on results of a commercial gamma interferon assay for diagnosis of tuberculosis in cattle. J Vet Diagn Invest (2001) 0.94
Outpatient in vitro fertilization using transvaginal ultrasound-guided oocyte retrieval. Obstet Gynecol (1987) 0.94
A long-term study in Merino sheep experimentally infected with Mycobacterium avium subsp. paratuberculosis: clinical disease, faecal culture and immunological studies. Vet Microbiol (2004) 0.92
Physiological and morphological characteristics of spinal neurons projecting to the parabrachial region of the cat. Somatosens Mot Res (1993) 0.92
Factors associated with ED use by "repeater" and "nonrepeater" patients. J Emerg Nurs (1982) 0.91
Sensitivity of human gamma interferon assay and tuberculin skin testing for detecting infection with Mycobacterium tuberculosis in patients with culture positive tuberculosis. Tuberculosis (Edinb) (2005) 0.91
A long-term study in Angora goats experimentally infected with Mycobacterium avium subsp. paratuberculosis: clinical disease, faecal culture and immunological studies. Vet Microbiol (2005) 0.90
Immune responses of white-tailed deer (Odocoileus virginianus) to Mycobacterium bovis BCG vaccination. J Wildl Dis (2004) 0.90
Induction of cyclooxygenase-2 in human umbilical vein endothelial cells by lysophosphatidylcholine. J Clin Invest (1995) 0.89
Validity of the Peabody Developmental Gross Motor Scale as an evaluative measure of infants receiving physical therapy. Phys Ther (1995) 0.89
Spinal pathways mediating tonic, coeruleospinal, and raphe-spinal descending inhibition in the rat. J Neurophysiol (1987) 0.89
Bromophenacyl bromide binding to the actin-bundling protein l-plastin inhibits inositol trisphosphate-independent increase in Ca2+ in human neutrophils. Proc Natl Acad Sci U S A (1994) 0.89
Structural equation modeling and its relationship to multiple regression and factor analysis. Res Nurs Health (1998) 0.88
Cryopreservation of human lymphocytes for assessment of lymphocyte subsets and natural killer cytotoxicity. J Immunol Methods (1986) 0.88
The family with cancer. Nursing interventions throughout the course of living with cancer. Cancer Nurs (1988) 0.88
Treatment of patients with atopic dermatitis using wet-wrap dressings with diluted steroids and/or emollients. An expert panel's opinion and review of the literature. J Eur Acad Dermatol Venereol (2006) 0.87
Glomerular structure in type-1 (insulin-dependent) diabetic patients with normo- and microalbuminuria. Kidney Int (1992) 0.87
Lunar association with suicide. Suicide Life Threat Behav (1977) 0.87
Bartonella spp. infection in healthy and sick horses and foals from the southeastern United States. J Vet Intern Med (2012) 0.87
Monoclonal antibodies to human squamous cell carcinoma of the lung and their application to tumor diagnosis. Cancer Res (1985) 0.85
Production and characterization of monoclonal antibodies specific for bovine gamma-interferon. Vet Immunol Immunopathol (1990) 0.85
A comparison of the sensitivity and specificity of enzyme immunoassays and time-resolved fluoroimmunoassay. J Immunol Methods (1991) 0.85
Improving compliance for asthmatic patients visiting the emergency department using a health belief model intervention. J Asthma (1987) 0.85
The expression of Fos-labeled spinal neurons in response to colorectal distension is enhanced after chronic spinal cord transection in the rat. Neuroscience (2002) 0.84
Dysphagia after head trauma: the effect of cognitive-communicative impairments on functional outcomes. J Head Trauma Rehabil (1999) 0.83
Genetic speciation of Candida isolates by arbitrarily primed polymerase chain reaction. FEMS Microbiol Lett (1996) 0.82
Osteoporosis prevention in young women. Orthop Nurs (1999) 0.81
Microcarrier enhanced survival of human and rat fetal ventral mesencephalon cells implanted in the rat striatum. Cell Transplant (1998) 0.80
Identification of Bartonella henselae in a horse from Germany. Vet Microbiol (2011) 0.80
Measurement screen for leg length and scoliosis. Phys Ther (1976) 0.80
Assessing disulfiram compliance: validational study of an abbreviated breath test procedure. Addict Behav (1983) 0.80
Induction of HIV-1-specific T-helper responses and type 1 cytokine secretion following therapeutic vaccination of macaques with a recombinant fowlpoxvirus co-expressing interferon-gamma. J Med Primatol (2000) 0.80
Moxifloxacin pharmacokinetics in horses and disposition into phagocytes after oral dosing. J Vet Pharmacol Ther (2004) 0.79
Pharmacokinetics of azithromycin in foals after i.v. and oral dose and disposition into phagocytes. J Vet Pharmacol Ther (2002) 0.79
Immunoglobulins intrinsic to colorectal carcinoma: an unfavorable prognostic association with IgM. J Natl Cancer Inst (1983) 0.79
Identification of patients in need of psychiatric intervention: visiting an emergency facility. Med Care (1978) 0.79
Use of ultrasound to evaluate outcome following colic surgery for equine large colon volvulus. Equine Vet J (2010) 0.79
Effects of vagal afferent nerve stimulation on noxious heat-evoked Fos-like immunoreactivity in the rat lumbar spinal cord. J Comp Neurol (1994) 0.78
Persistence of organ- and iso-antigens in vitro in a long-term culture cell line of colonic carcinoma. Pathology (1982) 0.78
Monoclonal antibodies to human colon and colorectal carcinoma. Br J Cancer (1983) 0.78
Effects of preexposure to dexfenfluramine, phentermine, dexfenfluramine-phentermine, or fluoxetine on sibutramine-induced hypophagia in the adult rat. Pharmacol Biochem Behav (2003) 0.78
Human cytomegalovirus (CMV)-specific CD8+ T cell responses are reduced in HIV-infected individuals with a history of CMV disease despite CD4+ T cell recovery. Clin Immunol (2007) 0.78
A randomized trial to improve compliance in urinary tract infection patients in the emergency department. Ann Emerg Med (1990) 0.78
Effect of selective inhibition of thromboxane synthesis on renal function in diabetic nephropathy. J Lab Clin Med (1993) 0.78
[Immunohistological analysis of lymphocytes infiltrating the terminal ileum in a patient with intestinal Behçet's disease]. Ryumachi (1986) 0.78
Hospital location as a determinant of emergency room utilization patterns. Public Health Rep (1982) 0.78
Effects of morphine given in the brain stem on the activity of dorsal horn nociceptive neurons. Prog Brain Res (1988) 0.78
Immunization against learned helplessness in man. J Abnorm Psychol (1977) 0.78
Expression of cell cycle proteins in 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced mouse lung tumors. Exp Lung Res (1998) 0.78
Effect of spinal norepinephrine depletion on descending inhibition of the tail flick reflex from the locus coeruleus and lateral reticular nucleus in the rat. Brain Res (1987) 0.77
Contribution of the site of heating to variability in the latency of the rat tail flick reflex. Brain Res (1987) 0.77
Reproductive genetic technologies. Exploring ethical and policy implications. AWHONN Lifelines (2002) 0.77
Skill training with alcoholics: a clinical extension. Addict Behav (1982) 0.77
Specificity of antibodies present in human periapical lesions. J Endod (1991) 0.77
Factors in choosing an urgent care center versus an emergency department. J Emerg Nurs (1988) 0.77
Diagnostic implications of antigen-induced gamma interferon production by blood leukocytes from Mycobacterium bovis-infected reindeer (Rangifer tarandus). Clin Vaccine Immunol (2006) 0.77
Spinal trauma board. Phys Ther (1977) 0.76
Re-feeding after starvation involves a temporal shift in the control site of glycogen synthesis in rat muscle. Biochem J (1998) 0.76
Mouse models of neurofibromatosis. Biochim Biophys Acta (2001) 0.76
Role of neutrophils in intestinal mucosal injury. J Am Vet Med Assoc (2000) 0.76
Increased assembly of clathrin occurs in response to mitogenic activation of murine lymphocytes. J Biol Chem (1989) 0.76
Chorionic villus sampling: experience with an initial 940 cases. Obstet Gynecol (1988) 0.76
Blood rheology and cardiovascular risk factors in type 1 diabetes: relationship with microalbuminuria. Diabet Med (1991) 0.76
Evaluation of television consultations between a large neonatal care hospital and a community hospital. Med Care (1980) 0.76
Dilution of samples collected and transported for Gen-Probe PACE 2 processing facilitates detection of Chlamydia trachomatis by Roche Amplicor PCR. J Clin Microbiol (1997) 0.75
Pregnancy screening for cystic fibrosis. Lancet (1993) 0.75
Electromagnetic field interference and cardiac pacemakers. Phys Ther (1976) 0.75
The psychiatric clinical nurse specialist/nurse practitioner: an example of a combined role. Arch Psychiatr Nurs (1998) 0.75
Diagnosis of tuberculosis. Lancet (2003) 0.75